University of Pennsylvania · NeuroscienceEpilepsy Treatment Optimization Lab
Kathryn Adamiak Davis · Philadelphia, Pennsylvania
Research Focus
Dr. Kathryn Adamiak Davis leads a research lab focused on improving treatment outcomes for patients with drug-resistant epilepsy. The lab investigates the use of biomarkers to predict how well patients will respond to a device called responsive neurostimulation (RNS) that helps control seizures. By analyzing clinical and brain activity data, the lab aims to develop a predictive signature that could guide better treatment decisions for individuals seeking relief from their seizures.
epilepsyresponsive neurostimulationbiomarkersmachine learningintracranial EEG
Research Aims
5AIM 01Develop predictive biomarkers for seizure outcomes in epilepsy patients
AIM 02Analyze multimodal patient data to enhance treatment decision making
AIM 03Collaborate across clinical sites for data collection and analysis
AIM 04Validate biomarkers through longitudinal studies in diverse patient populations
AIM 05Improve patient selection for responsive neurostimulation therapy
Skills the Lab Values
machine learningintracranial EEG analysisclinical data managementfederated data processingbiostatistics
Output against the department
Publications264top 27% of dept.181st of 671
this lab
most publishedleast published
Citations10.0ktop 40% of dept.271st of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.